Abstract
To compare the effect of IV magnesium with other antihypertensives in emergency department (ED) patients with hypertension. ED patients with a systolic BP > 135 mmHg or diastolic BP > 85 were approached for entry into the study. Those granting consent were randomly placed into one of three treatment groups: (1) 1.5 gm IV MgSO4 (n = 42), (2) a parenteral or oral antihypertensive agent (n = 41), (3) both IV MgSO4 and an antihypertensive agent (n = 44). Systolic and diastolic blood pressures were measured at entry into the study and at 15, 30, 45, and 60 min after magnesium or other antihypertensive medications were given. The main outcome measure was blood pressure at 60 min, and results were compared using one-way analysis of variance with the post hoc Tukey HSD test. Compared to systolic and diastolic blood pressures at time 0, both were lower at 15, 30, 45, and 60 min in all groups (p < 0.05). No significant difference in systolic or diastolic BP at any time point was observed when response to treatment was compared between the three groups. Intravenous MgSO4 is as effective as antihypertensives at lowering BP in emergency department patients.
Similar content being viewed by others
References
Laurant P, Touyz RM (2000) Physiological and pathophysiological role of magnesium in the cardiovascular system: implications in hypertension. J Hypertens 18:1177–1191
Resnic LM, Gupta RK, DiFabio B, Barbagallo M, Mann S, Marion R, Laragh JH (1994) Intracellular ionic consequences of dietary salt loading in essential hypertension. Relation to blood pressure and effects of calcium channel blockade. J Clin Invest 94:1269–1276
Miller MA, Sagnella GA, Markandu ND, MacGregor GA (1994) Comparison of calcium, magnesium-ATPase activity and membrane fluidity in patients with essential hypertension and in normotensive controls. J Hypertens 12(8):929–938
Altura BM, Zhang A, Altura BT (1993) Magnesium, hypertensive vascular disease, atherogenesis, subcellular compartmentation of Ca++ and Mg++ and vascular contractility. Miner Electrolyte Metab 19:323–336
Fujita T, Ito Y, Ando K, Noda E, Ogata H (1990) Attenuated vasodilator responses to Mg++ in young patients with borderline hypertension. Circulation 82:384–393
Nishio A, Gebrewold A, Altura BT, Altura BM (1998) Comparative effects of magnesium salts on reactivity of arterioles and venules to constrictors agents: an in situ study on microcirculation. J Pharmacol Exp Ther 246:859–865
Sontia B, Touyz RM (2007) Role of magnesium in hypertension. Arch Biochem Biophys 458:33–39
Mahboob T, Mumtaz M, Halem MA (1996) Electrolyte content of serum, erythrocyte, kidney and heart tissue in salt induced hypertensive rats. Life Sci 5999:731–737
Berthelot A, Luthringer C, Meyers E, Exinger A (1987) Disturbances of magnesium metabolism in the spontaneously hypertensive rats. J Am Coll Nutr 6:329–332
Laurant P, Kantelip JP, Berthelot A (1995) Dietary magnesium supplementation modifies blood pressure and cardiovascular function in mineralocorticoid-salt hypertensive rats but not in normotensive rats. J Nutr 125:830–841
Jones MR, Martins JE, Clemens RA (1988) Mineral balance and blood pressure in the young, spontaneously hypertensive rat. J Nutr 118:114–120
Wells IC, Agrawal DK (1992) Abnormal magnesium metabolism in two rat models of genetic hypertension. Can J Physiol Pharmachol 70:1225–1229
Jelics LA, Gupta RK (1991) Intracellular free magnesium and high energy phosphates in the perfused normotensive and spontaneously hypertensive rat heart. Am J Hypertens 4:131–136
Altura BM, Altura BT, Gebrewold A, Ising H, Günther TA (1992) Noise-induced hypertension and magnesium in rats: relationship to microcirculation and calcium. J Appl Physiol 72:194–202
Blache D, Devaux S, Joubert O, Loreau N, Schneider M, Durand P, Prost M, Gaume V, Adrian M, Laurant P, Berthelot A (2006) Long-term moderate magnesium-deficient diet shows relationships between blood pressure, inflammation and oxidant stress defense in aging rats. Free Radic Biol Med 41:277–284
Kawano Y, Matsuoka H, Takishita S, Omae T (1998) Effects of magnesium supplementation in hypertensive patients. Assessment by office home and ambulatory blood pressures. Hypertension 32:260–265
Resnic LM, Bardicef O, Altura BT, Alderman MH, Altura BM (1997) Serum ionised magnesium: relation to blood pressure and radical factors. Am J Hypertens 10:1420–1424
Kisters K, Tepel M, Spieker C, Zidek W, Barenbrock M, Tokmak F, Kosch M, Hausberg M, Rahn KH (1998) Decreased membrane Mg++ concentrations in a subgroup of hypertensives. Am J Hypertens 11:1390–1393
Song Y, Sesso H, Manson JE, Cook NR, Buring JE, Liu S (2006) Dietary magnesium intake and risk of incident hypertension among middle aged and older US women in a 10-year follow-up study. Am J Cardiol 98:1616–1621
Mazur A, Maier JAM, Rock E, Gueux E, Nowacki W, Rayssiguier Y (2007) Magnesium and the inflammatory response: potential physiopathological implications. Arch Biochem Biophys 458:48–56
Laurant P, Gaillard E, Kantelip JP, Berthelot A (1996) Lack of magnesium supplementation effects on blood pressure and vascular responsiveness in aged spontaneously hypertensive rats. Magnesium Bull 18:38–43
Touyz RM, Milne FJ (1999) Magnesium supplementation attenuates, but does not prevent, the development of hypertension in spontaneously hypertensive rats. Am J Hypertension 12:757–765
Kawasaki T, Itoh K, Kawasaki M (1998) Reduction in blood pressure with a sodium-reduced potassium and magnesium-enriched salt in subjects with mild essential hypertension. Hypertens Res 21:235–243
Sanjuliani AF, Abreu Fagundes VG, Francischetti EA (1996) Effect of magnesium on blood pressure and intracellular ion levels of Brasilian hypertensive patients. Int J Cardiol 56(2):177–183
Suter PM (1999) The effects of potassium, magnesium, calcium, and fiber on risk of stroke. Nutr Rev 57:84–88
Pastori C, Delva P, Degan M, Lechi A (1999) Preliminary communication on intralymphocyte ionised magnesium in hypertensive patients under treatment with beta-blockers. Magnes Res 1291:49–55
Katz A, Rosenthal T, Maoz C, Peleg E, Zeidenstein R, Levi Y (1999) Effect of a mineral salt diet on 24 h-blood pressure monitoring in elderly hypertensive patients. J Hum Hypertens 13:777–1780
Beyer FR, Dickinson HO, Nicholson DJ, Ford GA, Mason J (2006) Combined calcium, magnesium and potassium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev 3:CD004805
Robert JM, Redman CW (1993) Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 341:1447–1451
Belfort MA, Moise KJ (1992) Effect of magnesium sulfate on maternal brain blood flow in preeclampsia: a randomised placebo-controlled study. Am J Obstet Gynecol 167:661–666
Standley CA, Batia L, Yueh G (2006) Magnesium sulfate effectively reduces blood pressure in an animal model of preeclampsia. J Matern Fetal Neonetal Med 19:171–176
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bayır, A., Kara, H., Ak, A. et al. Magnesium Sulfate in Emergency Department Patients with Hypertension. Biol Trace Elem Res 128, 38–44 (2009). https://doi.org/10.1007/s12011-008-8256-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-008-8256-y